TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
ANDOVER, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced …